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A B S T R A C T
The aims of this study were to assess prevalence and symptom profile of premenstrual dysphoric disorder (PMDD) in
a sample of Croatian students and young university graduates. We obtained data for 87 healthy women, aged 18–30, at
their regular gynecologic outpatient visits over the period of 2003 to 2004. The severity of premenstrual symptoms were
assessed daily, during two cycles, with the Daily Record of Severity of Problems (DRSP) and criteria for PMDD accord-
ing to DSM-IV were applied. Fifteen out of 87 women fulfilled PMDD criteria and reported statistically significantly
higher prevalence of co morbid disorders in their medical history compared to non-PMDD group. The most common
symptoms in the PMDD group were psychological, while in non-PMDD group were vegetative. Overall, relatively high
prevalence of PMDD in studied group indicates the need to continue the study.
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Introduction
Premenstrual syndrome (PMS) includes a broad group
of emotional and physical symptoms that occur in luteal
phase of the menstrual cycle for ten to 14 days before men-
ses and subside following the menstrual period. Approxi-
mately 50–80% of women will experience at least a few
premenstrual symptoms that may vary from mild to
severe1,2. However, a smaller proportion of women in gen-
eral population have very severe premenstrual symptoms
which cause distress, social and occupational impairments
and may need treatment3. When premenstrual symptoms
are severe enough to cause marked disruptions in women’s
everyday life, the syndrome is known as premenstrual
dysphoric disorder (PMDD). In contrast to PMS which is
characterized mostly by somatic complaints, PMDD is
rather characterized by mental symptoms and is included
in the Diagnostic and Statistic Manual of Mental Disorders
(DSM-IV) as a variant of mood disorders4. Also, the antide-
pressant medications from the group of selective serotonin
reuptake inhibitors (Saris), which are the first line of treat-
ment for PMDD, appear to reduce most premenstrual com-
plaints, but seem to be more effective for mental symptoms
than for somatic complaints5.
Results from epidemiological studies pointed out that
prevalence of premenstrual dysphoric disorder or severe
premenstrual symptoms is rather consistent in different
population groups1,6, although may vary from 3% to 30%
depending upon studied age groups, usually with in-
creasing prevalence amongst aging cohorts7,8. Also, the
results depend upon the diagnostic criteria and method-
ology applied4,7, and in some studies the number of symp-
toms may not meet the arbitrary number of 5 symptoms
on the PMDD list. When more rigorous criteria are ap-
plied, as according to the DSM-IV, the prevalence of
women who meet criteria for PMDD is 3–8%3.
According to numerous epidemiological studies, a sig-
nificant proportion of women who suffer from PMDD
also suffer from other co morbid disorders, especially
from depressive and anxiety spectrum9,10. Certain life-
styles and exposure to greater stress or stressful life
events can also influence the severity of PMDD symp-
toms11. Also, several studies reported opposite results
concerning the relationship between education and em-
ployment, and the prevalence of PMDD1,2,11.
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In clinical settings, diagnosis of PMDD is usually
made based on an interview, with symptom rating scales
made on monthly, weekly or daily basis. However, month-
ly or weekly scales, along with retrospective scales usu-
ally provide insufficient and perhaps unreliable data re-
flecting just an average experience, without showing the
relationship between the symptoms and the menstrual
cycle12. Therefore, daily patient reports on the symptoms
during two to three cycles remain the most useful diag-
nostic tool, and provide comparable and replicable data,
suitable for research purposes13.
Despite the prevalence of the disorder and the avail-
ability of its treatment, PMDD still remains unrecog-
nized by many lay people and health care professionals
and therefore is rarely diagnosed and adequately treated
in our community. As to our knowledge, this is the first
study of PMDD performed in Croatia. Our hypothesis is
that a significant proportion of women in our community
suffers from PMDD. We believe they might be unaware
of the treatment options, despite their educational level.
Therefore, we conducted a preliminary study, with the
aims to asses the possible prevalence of PMDD among
students and young university graduates and identify
some potential factors that could have some influence on
the prevalence itself. Also, we inquired participant’s atti-
tude toward potential treatment options.
Materials and Methods
We recruited 200 healthy women, aged 18–30, stu-
dents and university graduates, at their regular gyneco-
logic outpatient visits during the period from 2003 to
2004. The women were offered to participate in our
study, and were explained the purpose and aims of the
study, as well as what was expected from their participa-
tion. All participants gave the informed consent. Women
with serious somatic diseases including anemia, endome-
triosis, chronic pain syndrome, diabetes, per menopause,
thyroid disorders and malignant illness were not in-
cluded in the study.
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TABLE 1
SOCIODEMOGRAPHIC DATA, EVALUATION OF CURRENT LIFE SITUATION AND STRESS LEVEL OF »RESPONDERS«,
»NON-RESPONDERS«, AND TOTAL SAMPLE
Responders Non-responders Total
n % n % n %
Marital status Single 78 87% 99 90% 180 90%
Married 12 13% 11 10% 20 10%
Total 90 100% 110 100% 200 100%
Number of children None 84 93% 103 94% 178 94%
1 and more 6 7% 7 6% 12 6%
Total 90 100% 110 100% 200 100%
Education Students 71 79% 85 77% 154 77%
University graduates 19 21% 25 23% 46 23%
Total 90 100% 110 100% 200 100%
Marital problems Not married 78 87% 99 90% 180 90%
Without 4 4% 3 3% 6 3%
Average 8 9% 8 7% 14 7%
More then average 0 0% 0 0% 0 0%
Total 90 100% 110 100% 200 100%
Financial problems Without 25 28% 16 15% 36 18%
Average 59 66% 88 80% 154 77%
More then average 6 7% 6 5% 10 5%
Total 90 100% 110 100% 200 100%
Problems at work/school Without 5 6% 7 6% 12 6%
Average 75 83% 90 82% 164 82%
More then average 10 11% 13 12% 24 12%
Total 90 100% 110 100% 200 100%
Participant feels under stress No 47 52% 51 46% 84 47%
Yes 43 48% 59 54% 106 53%
Total 90 100% 110 100% 200 100%
Responders vs. Non-responders were analysed with c2, all p=n.s.
The study was performed in two steps. First, all partic-
ipants filled in a questionnaire which included general
data (age, marital status, number of children, education),
evaluation of current life situation and stress level, psy-
chiatric anamnesis, gynecologic anamnesis (duration of
menstrual cycle, duration of menstrual bleeding, premen-
strual pain, use of non steroidal anti-inflammatory drugs
(NSAID), use of contraceptive pills, complaints about
premenstrual symptoms) and family anamnesis (psychiat-
ric illnesses, PMS). Also, all participants were asked about
their attitude towards first line medications for PMDD,
the antidepressants. After they filled in the first question-
naire, they were asked to assess the severity of their
premenstrual symptoms daily during two cycles, with the
Daily Record of Severity of Problems (DRSP). Severity of
symptoms was ranged from 1 to 6 (1 – not at all, 2 – mini-
mal, 3 – mild, 4 – moderate, 5 – severe, 6 – extreme). DRSP
includes 11 symptoms: four »major« symptoms (depressed
mood, anxiety/tension, mood swings, anger/irritability) and
seven »minor« (decreased interest in usual activities, sub-
jective poor concentration, lethargy/lack of energy, change
in appetite/ overeating, insomnia/sleeping too much, feel-
ing overwhelmed or out of control, physical symptoms).
Diagnostic criteria according to DSM-IV were applied.
To be able to diagnose PMDD according to the DSM-IV,
at least 5 of the 11 symptoms (one of which must be »ma-
jor«) at a severe level (4 or more) during premenstrual
period and low level (3 or less) during postmenstrual pe-
riod must be met. At least one of the problems noted
above causes severe impairment (4 of more) at work,
avoidance or less participation in hobbies or social activi-
ties and impaired relationships with others. Also, differ-
entiation from other disorders and confirmation by a
least two cycles of prospective daily symptom ratings is
required (4). Statistical differences were tested by chi-
square test (c2 test) and ANOVA, p=0.05 or less was con-
sidered statistically significant.
Results
In total, we collected all data from 87 participants.
Both questionnaires were completed by 90 out of 200
participants, but 3 of them were not valid for complete
statistical analysis because of the uncompleted data in
the DRSP. Because of a large drop out, we compared the
group of participants who filled in and returned both
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TABLE 2
CHARACTERISTICS OF THE GYNECOLOGIC, PSYCHIATRIC AND FAMILY ANAMNESIS OF »RESPONDERS«, »NON-RESPONDERS«,
AND TOTAL SAMPLE
Responders Non-responders Total
n % n % n %
Menstrual pain No 34 38% 46 42% 82 41%
Yes 56 62% 64 58% 108 59%
Total 90 100% 110 100% 200 100%
Participant complain of premenstrual symptoms No 36 40% 54 40% 80 40%
Yes 54 60% 66 60% 120 60%
Total 90 100% 110 100% 200 100%
Uses oral contraceptives No 65 72% 70 73% 146 73%
Yes 25 28% 30 27% 54 27%
Total 90 100% 110 100% 200 100%
Uses non steroidal anti-inflammatory drugs No 55 61% 134 67% 132 66%
Yes 45 49% 36 33% 68 34%
Total 90 100% 110 100% 200 100%
PMS in family No 44 49% 66 51% 100 50%
Yes 46 51% 54 49% 100 50%
Total 90 100% 110 100% 200 100%
Psychiatric disorders in family No 80 89% 95 86% 174 87%
Yes 10 11% 15 14% 26 13%
Total 90 100% 110 100% 200 100%
Co morbid psychiatric disorder No 88 98% 107 97% 194 97%
Yes 2 2% 3 3% 6 3%
Total 90 100% 110 100% 200 100%
Responders vs. Non-responders were analysed with c2, all p=n.s.
questionnaires (we will refer to this group as »respond-
ers«) with the group of participants who filled in only the
first questionnaire, and didn’t fulfill DRSP (»non-re-
sponders«). We found no statistically significant differ-
ences in each item analyzed (general data, evaluation of
current life situation and stress level, gynecologic, psy-
chiatric and family anamnesis) (Table 1 and 2).
Subsequently, we analyzed the group of »responders«.
Each participant reported at least one premenstrual
symptom. Fifteen out of 87 women fulfilled PMDD crite-
ria (PMDD group). Women who didn’t fulfill PMDD cri-
teria or fulfilled PMDD criteria only in one menstrual cycle
were included in the non-PMDD group. Major complaints
of subjects with premenstrual dysphoric disorder in-
cluded depressive mood, physical symptoms, anxiety/ten-
sion, mood swings and anger or irritability while major
complaints of subjects without PMDD included physical
symptoms, change in appetite or overeating and leth-
argy/lack of energy followed by affective symptoms (Ta-
ble 3a and 3b). Mean values of severity of each of eleven
symptoms were significantly higher in the PMDD group
when compared to non-PMDD group (data not shown).
We found no statistical difference comparing general
data between the PMDD and the non PMDD groups: age
(MPMDD 25.47, SD 4,207 vs. MNon-PMDD 24.08, SD 3,183,
p=0.152), marital status, number of children, years of
education and evaluation of current life situation and
stress level (data not shown). No statistical difference be-
tween groups was found when comparing the length of
menstrual cycle (MPMDD 27.95  SD 2,12 vs. MNon-PMDD
30.54  SD 7,23, p=0.863), the length of menstrual
bleeding (MPMDD 5.07  SD 1,03 vs. MNon-PMDD 5.14  SD
0,98, p=1.000), the frequency of menstrual pain, use of
NSAID and oral contraceptives or positive family anam-
nesis of PMS. Interestingly, there were no statistically
significant differences between groups concerning fre-
quency of premenstrual complaints reported in the first
questionnaire, as in both groups about two thirds of
women noticed the occurrence of their premenstrual
symptoms. The PMDD group reported more often co
morbid disorders (depressive and anxiety spectrum dis-
orders) in their medical history compared to non-PMDD
group (p=0.028, Table 4).
Analyzing attitude toward treatment, we found that
about 80% of all participants would accept treatment
with psychiatric medications if they suffered from severe
premenstrual syndrome and about 20% of participants
would refuse the medical treatment. About 10% would
refuse treatment because of fear of side effects (including
fear of becoming addicted to drugs), about 50% stated
preference for alternative treatment options (defined as
»natural« medication, »alternative« medication, herbal
drugs) and about 40% would refuse of all available medi-
cations for premenstrual symptoms. Furthermore, we
found no statistically significant difference between the
PMDD group and the non-PMDD group in percentage of
women who had positive attitude toward antidepressant
treatment, nor did we found it in analyzing reasons for
negative attitude with c2 test.
Discussion
Study results indicate that prevalence of PMDD is
about 17%, which is higher then could be expected ac-
cording to results of many prevalence studies in other
countries1–3,6. Considering reports of prevalence with ag-
ing cohorts6,7,14, it is interesting to observe the younger
age of our subjects. Also, some authors pointed out the
possibility that women with dysphoric premenstrual syn-
drome are underestimated in epidemiological studies
that follow DSM-IV criteria. Thus, they may need treat-
ment although do not meet DSM-IV criteria for PMDD
due to a smaller number of symptoms reported4. There-
fore, considering the restrictive nature of the criteria we
used, we could expect even higher prevalence of women
who may need treatment when applied less restrictive
PMDD criteria as is usually done in clinical settings.
Although participants in our study were students or
university graduates and considering the possibility that
their higher level of education or specific personality
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TABLE 3A
SYMPTOM FREQUENCIES AND PORTIONS FOR SUBJECTS
WITH PREMENSTRUAL DYSPHORIC DISORDER (N=15)
Symptom N Portion
Depressed mood 15 1
Physical symptoms 15 1
Anxiety, tension 13 0.87
Mood swings 12 0.8
Anger or irritability 12 0.8
Lethargy, lack of energy 11 0.73
Change in appetite, overeating 9 0.61
Insomnia or sleeping too much 9 0.61
Subjective poor concentration 8 0.56
Decreased interest in usual activities 5 0.33
Feeling overwhelmed or out of control 2 0.14
TABLE 3B
SYMPTOM FREQUENCIES AND PORTIONS FOR SUBJECTS
WITHOUT PREMENSTRUAL DYSPHORIC DISORDER (N=72)
Symptom N Portion
Physical symptoms 72 1
Change in appetite, overeating 33 0.47
Lethargy, lack of energy 30 0.42
Mood swings 28 0.39
Anxiety, tension 26 0.36
Anger or irritability 25 0.35
Insomnia or sleeping too much 22 0.3
Depressed mood 16 0.22
Decreased interest in usual activities 9 0.12
Feeling overwhelmed or out of control 9 0.12
Subjective poor concentration 8 0.11
traits (i.e. ambitiousness) somehow influence the preva-
lence of PMDD, reported prevalence is still high compar-
ing to other studies1,2,14. However, considering the low re-
sponse rate of the participants it is possible that high
prevalence of PMDD found in group of »responders«
(participants who filled out both questionnaire and
DRSP) does not truly reflect the prevalence of the whole
sample. Although when comparing those two groups in
each item we found no statistically significant differences
among them, we point out that they could have differed
somehow in other non analyzed items, i.e. may be highly
motivated or have specific personality traits.
Post-war period in Croatia is characterized with nu-
merous social, economic and cultural consequences that
could be expected to increase the prevalence of the disor-
der15,16. Lower socioeconomic status and transitional
changes in a postwar society put additional social re-
quirements that could have influenced our results17,18.
Indeed, about half of participants reported that they felt
under stress. Also, high prevalence of traumatic war
events and their consequences, such as anxiety, depres-
sion and PTSD were shown to influence premenstrual
symptoms19,20. That is consistent with our finding which
clearly show that co morbid psychiatric disorders (anxi-
ety and depressive spectrum disorders) are significantly
more common in PMDD group, when compared to the
group of participants who didn’t fulfill PMDD criteria
(13% vs. 0%). These findings are consistent with previ-
ous research results9,10. However, regardless of co morbid
disorders, all women in the PMDD group reported pre-
menstrual depressive mood, followed by other psycholog-
ical symptoms (anxiety/tension, mood swings and anger
or irritability) while women in non-PMDD group mostly
reported vegetative symptoms (physical symptoms,
change in appetite or overeating and lethargy/lack of en-
ergy), followed by mood swings. Although all women in
PMDD group also reported premenstrual physical symp-
toms, the mean value of severity of physical symptoms
was significantly higher in this group, than compared to
non-PMDD group. Similarly, previous studies reported
that the most common premenstrual symptoms in gen-
eral population are physic symptoms, swelling or weight
gain18, or mild psychological discomfort11, while depres-
sive mood is more common in severe PMS3. Although
many researchers emphasized similarities between PMDD
and anxiety disorders, others believe that PMDD is a
variant of mood disorders19,20. Since we found that de-
pression is far more common in PMDD group, while veg-
etative symptoms, followed by mood swings (but not de-
pression) are more common in non-PMDD group, we
believe that our findings support the DSM-IV’s concept
of PMDD as a mood disorder.
Our study showed that only about two thirds of wo-
men reported the occurrence of their premenstrual sym-
ptoms in the first questionnaire, regardless of PMDD di-
agnosis. However, when they assessed the severity of
their premenstrual symptoms daily during two cycles
with DRSP, each subject noted at least one premenstrual
symptom. Thus, it is possible that one third of all women,
either suffering from PMDD or not, don’t actually relate
their symptoms to the menstrual cycle and thus are un-
aware of the disorder itself and the need for treatment.
Indeed, previous studies showed that women who seek
treatment for severe premenstrual symptoms more often
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TABLE 4
CHARACTERISTICS OF THE GYNECOLOGIC, PSYCHIATRIC AND FAMILY ANAMNESIS IN THE PREMENSTRUAL
DYSPHORIC DISORDER (PMDD) AND NON-PMDD GROUP
PMDD Non-PMDD Total PMDD vs. Non-PMDD
N Portion N Portion N Portion ÷2 df p
Total 15 0.17 72 0.83 87 1.00
Menstrual pain No 6 0.33 26 0.36 32 0.37 0.081 1 1.000
Yes 9 0.66 46 0.64 55 0.63
Participant complain of premenstrual symptoms No 5 0.33 29 0.40 34 0.39 0.251 1 0.774
Yes 10 0.66 43 0.60 53 0.61
Uses non steroidal anti-inflammatory drugs No 7 0.47 30 0.43 37 1.00 0.081 2 1.000
Yes 9 0.53 42 0.57 51 1.00
Uses oral contraceptives No 12 0.8 49 0.69 61 0.71 0.725 1 0.537
Yes 3 0.2 22 0.31 25 0.29
Premenstrual symptoms in family (mother, sister) No 6 0.4 35 0.49 41 0.47 0.369 1 0.583
Yes 9 0.6 37 0.51 46 0.53
Psychiatric disorders in family No 13 0.87 64 0.9 77 0.9 0.690 1 1.000
Yes 2 0.13 7 0.1 9 0.1
Co morbid psychiatric disorder No 13 0.87 72 0.98 85 1.00 9.826 1 0.028
Yes 2 0.13 0 0.2 2 1.00
have other co morbid disorders (depression, obsessive
compulsive, phobia, personality disorder)9–11 but also more
often visit a doctor19, compared to women who also suffer
from severe premenstrual symptoms but don’t seek treat-
ment.
Our study shows that about 80% of participants would
accept treatment with psychiatric medication, if they
suffered from severe PMS. However, our results indicate
that none of the participants relieves their premenstrual
symptoms with any psychiatric medication. Since antide-
pressants are the first line treatment for severe PMS, it
appears that many women are left without proper care5.
One previous study showed that fluoxetine, used for se-
vere premenstrual symptoms is usually proscribed by
family medicine specialist (52%), gynecologist (40%) and
psychiatrist in only 6% of cases. The same study showed
that the most of women use NSAID (50%) or alternative
methods (2%)21. Our participants also use NSAID (50%)
over the counter and oral contraceptives (although pro-
scribed for other reasons) (about 20 %). Furthermore,
about half of those who refuse treatment stated their
preference for alternative methods, what could indicate a
potentially higher percentage of women prone to reliev-
ing their symptoms by alternative methods. Lifestyles
and self medication provide only partial explanation for
the small number of women seeking treatment for pre-
menstrual symptoms from family medicine specialist, gy-
necologist or psychiatrist. A question arises whether that
fact reflects the lack of information about the disorder
and its treatment, both among lay men and profession-
als, especially since we studied population of students
and university graduates, which were expected to be the
best informed young population group. Also, it indicates
the lack of awareness of other problems which are conse-
quence of untreated PMDD, as the increased use of
health care and impaired working productivity17. There-
fore we stress out the need for a more active and coordi-
nated approach of the professionals, including family
medicine specialists, gynecologists and psychiatrists.
Our results point out the possibility that there could be a
substantial proportion of symptomatic women who have
premenstrual impairment and distress, and may seek
treatment, but are unaware of treatment options. As effi-
cacious treatments are available, we believe that recogni-
tion, clinically relevant diagnosis, and adequate treat-
ment should provide relief many women and also have
positive social impact.
We believe the results of our preliminary study indi-
cate the need to further continue the study, with a repre-
sentative population sample and greater impact on psy-
chiatric co morbidity and perhaps stressful events. We
also untraced a potential problem for our future study,
which is a large drop out that could greatly influence the
study results. We are not able to explain it considering
that we could not differentiate the group of »responders«
and the group of »non-responders« by any item analyzed.
However, other items such as motivation or specific per-
sonality traits, could be significant, and should be taken
into consideration for future studies.
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PREDMENSTRUALNI DISFORI^NI POREME]AJ – NEPRAVEDNO ZANEMARENA DIJAGNOZA?
PRELIMINARNO ISTRA@IVANJE U POPULACIJI STUDENTICA U HRVATSKOJ
S A @ E T A K
Ciljevi istra`ivanja su bili odrediti prevalenciju i naj~e{}e simptome predmenstrualnog disfori~nog poreme}aja (PMDD) u
populaciji studentica i mla|ih fakultetski obrazovanih `ena u Hrvatskoj. Prikazujemo rezultate istra`ivanja 87 zdravih
`ena, u dobi od 18–30 godina, koje su obavljale redoviti ginekolo{ki pregled u razdoblju 2003–2004. godine. Ispitanice su
na skali »Daily Record of Severity of Problems« (DRSP) svakodnevno ocjenjivale stupanj te`ine svojih predmenstrual-
nih simptoma kroz dva menstrualna ciklusa. Dijagnoza PMDD-a se postavljala prema kriterijima DSM-IV. Od 87 ispita-
nica, 15 je zadovoljilo kriterije za postavljanje dijagnoze PMDD-a. Te ispitanice su statisti~ki zna~ajno ~e{}e navodile
podatak o postojanju drugog psihijatrijskog poreme}aja u komorbiditetu, u odnosu na grupu ispitanica koje nisu zado-
voljavale kriterije za PMDD. Naj~e{}i predmenstrualni simptomi u grupi ispitanica s PMDD-om su bili psiholo{ki, dok
su u grupi ispitanica koje ne zadovoljavaju kriterije za PMDD bili vegetativni. Zaklju~no, relativno visoka prevalencija
PMDD-a u ispitivanom uzorku ukazuje na potrebu nastavka istra`ivanja.
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